The combination of antiagniogenic agents to inhibit primary tumor growth and metastasis

Journal of Pediatric Surgery

Volumn 28, Issue 10, 1993, Pages 1253-1257

  Brem, Harold ^a   Gresser, Ion ^a   Grosfeld, Jeffrey ^a   Folkman, Judah ^a  

^a NONE

Author keywords

AGM 1470; Angiogenesis, metastasis; antiangiogenic therapy; interferon; Lewis lung carcinoma; TNP 470

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; FUMAGILLOL CHLOROACETYLCARBAMATE;

ANGIOGENESIS; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; HEMANGIOMA; LEWIS CARCINOMA; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR VASCULARIZATION;

ANIMAL; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; COMPARATIVE STUDY; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG SYNERGISM; INTERFERON-ALPHA; INTERFERON-BETA; LUNG; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; SESQUITERPENES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS;

EID: 0027437920     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3468(05)80308-2     Document Type: Article

References (41)

1. Angiogenesis and inflammation
2. Tumor angiogenesis: Therapeutic implications
3. What is the evidence that tumors are angiogenesis-dependent?
4. Oncology overview on antiangiogenesis
5. Brain tumor angiogenesis
6. Tumor angiogenesis
7. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation
8. The significance of hematogenous tumor cell clumps in the metastatic process
9. What is the role of angiogenesis in metastasis from cutaneous melanoma? Perspectives and Commentaries
10. Tumor interactions with the vasculature
11. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth
12. Suppression of tumor metastasis by angiogenesis inhibition
13. Potent anti-angiogenic action of AGM-1470: Comparison to the fumagillin parent
14. Systemic administration of an angiogenesis inhibitor (AGM-1470), inhibits bFGF-induced corneal neovascularization
15. Mechanisms of endothelial growth control
16. Inhibition of angiogenesis by interferons: Effects on tumor and lymphocyte-induced vascular responses
17. Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice
18. Therapy of pulmonary hemangiomatosis with recombinant interferon alfa-2a
19. Successful treatment of an angiogenic disease
20. Interferon alfa 2a therapy for life-threatening hemangiomas in infancy
21. Analysis of experimental antiangiogenic therapy
22. A method for the large scale production of potent interferon preparations
23. Effectiveness of mouse interferon alpha/beta compared to single-agent chemotherapy in increasing survival time of mice after intravenous inoculatio of Friend erythroleukemia cells
24. Inhibition by interferon preparations of a solid malignant tumour and pulmonary metastases in mice
25. Inhibition of cell motility by interferon
26. 13-cis-retinoic acid plus interferon alpha-2a Highly active systemic therapy for squamous cell carcinoma of the cervix
27. Inhibition of angiogenesis through modulation of collagen metabolism
28. A new activity of herbimycin A: Inhibition of angiogenesis
29. Regulation of the activity of a new inhibitor of angiogensis by a cancer supressor gene
30. Tumor angiogenesis: The role of oncogenes and tumor suppressor genes
31. Angiogenesis
32. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides
33. Antitumor effect of GPA1734 in rat Walker 256 carcinoma
34. Identification of an inhibitor of neovascularization from cartilage
35. Regulators of angiogenesis
36. Angiostatic steroids potentiated by sulfated cyuclodextrins inhibit corneal neovascularization
37. The angiogenic phenotype in cancer
38. Angiogenesis inhibition by minocycline
39. Inhibitors of angiogenesis
40. The role of fibroblast growth factors and related oncogenes in tumor growth
41. Effect of angiostatic steroid with or without glucocorticoid activity on metastasis